Pneumococcal conjugate second or third-dose vaccines (PCVc) in Myanmar
Myanmar: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 71.0% in 2025. ◆ Volatile
Latest (2025)
71.0%
Change on year
unchanged
World rank
133rd
of 194 countries
All-time high
91.0%
in 2018
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Myanmar, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Myanmar stood at 71.0%.
The figure is down 17.4% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Myanmar peaked at 91.0% in 2018 and was at its lowest, 0.0%, in 2008.
Myanmar ranks 133rd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Myanmar, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 14.0% | — |
| 2017 | 89.0% | +535.7% |
| 2018 | 91.0% | +2.2% |
| 2019 | 90.0% | -1.1% |
| 2020 | 86.0% | -4.4% |
| 2021 | 40.0% | -53.5% |
| 2022 | 57.0% | +42.5% |
| 2023 | 64.0% | +12.3% |
| 2024 | 71.0% | +10.9% |
| 2025 | 71.0% | +0.0% |
Myanmar compared with similar countries
- Myanmar's 71.0% is below the median for lower middle income countries, which is 84.0%, 85% of the median. (47 countries reporting)
- Myanmar's 71.0% is below the median for East Asia & Pacific, which is 81.0%, 88% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 28.4% | 0.0% | 91.0% | 10 |
| 2020s | 64.8% | 40.0% | 86.0% | 6 |
Countries ranked near Myanmar
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate -0.759 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0387 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8351 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Myanmar?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Myanmar was 71.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Myanmar?
- The highest recorded value was 91.0% in 2018.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Myanmar?
- The lowest recorded value was 0.0% in 2008.
- How does Myanmar rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Myanmar ranks 133rd out of 194 countries with data for 2025.
- Where does this Myanmar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).